One Foolish contributor holds himself accountable.
A new, perhaps better, ETF offers investment in the country.
iShares may make a good investment in more ways than one.
Can it really make sense to own a French water company?
See how Foolish investors can use the new gold ETF and what it might mean for gold stocks.
Here's a way to benefit from an increase in the global demand for oil.
A good starting point to analyze a stock is the demand for its products.
Things are looking up for National Australia Bank, which could be a good foreign investment.
Generic drug companies like Teva may offer a smart way to own health care.
History does not support the notion of a real rally when the election ends.
Big copper has provided big results, but what's next for the share price?
Can the mutual fund firm do well in a bad environment for financial services?
Eli Lilly's numbers get lost in the wake of Merck and Pfizer.
E*Trade's quarterly report offers mixed numbers and a positive outlook.
There are things to watch out for as this investment theme plays out.
This American icon seems destined to lag for the forseeable future.
It's a different quarter, but the letdown looks the same.
How can the company win back the trust of shareholders?
Before you chase foreign investments, consider a few things first.
Globalization's changed how the world's markets interact -- and how your portfolio fares.